No issue is more central to global well-being than the health of mothers and their babies. Every individual, every family, every community at some point or another is intimately involved with pregnancy and the success of childbirth. And yet every day, 1,600 women and more than 10,000 newborns die due to complications that could have been prevented.
The challenges are the greatest in developing countries, where investment in health and other social sectors is dwindling. Health-care workers, infrastructure, equipment, and supplies are in short supply. Poor and underprivileged women continue to suffer the most.
Every year, there are more than 210 million pregnancies, of which nearly 87 million are either unwanted or unplanned. This is primarily due to a lack of access to good quality family planning services. At least 529,000 women and nearly 4 million newborn babies die each year and another 3.3 million are stillborn. Almost 90% of these deaths occur in sub-Saharan Africa and Asia.
About 40% of deaths in children under age 5 occur within the first 28 days of a baby's life. Newborn mortality is so intrinsically related to maternal health and well-being that unless countries address the issue of maternal health, newborn survival will fail to improve.
In many countries, particularly Africa, the prevalence of HIV/AIDS in pregnancy is alarmingly high, with more and more newborn babies testing positive for the disease. Many mothers die each year from HIV/AIDS, leaving thousands of children orphaned-and often infected with HIV.
In recent years, antenatal care services have proved successful in providing countries with a unique platform for prevention of HIV infection by keeping HIV-negative mothers free from infection, preventing transmission of HIV to their unborn babies, and by enrolling HIV-positive mothers for treatment.
Malaria in pregnancy is another challenge. Bed nets, malaria prophylaxis, and even basic treatments are not always available to pregnant women in most malaria-endemic countries. Without close collaboration between HIV/AIDS and malaria programs, the situation will not improve.
Since the inception of the Safe Motherhood Movement in 1987, we have learned a lot about what works to keep women safe during pregnancy and childbirth, and to save newborn lives. Addressing problems requires a well-functioning health system that encompasses all levels-from the community to referral facilities-and provides accessible, high-quality, and affordable care. Adequate supplies, skilled personnel, and an effective system for referral and transport are particularly important for managing obstetric emergencies.
The underlying medical causes of maternal deaths and disability are a range of social, economic, and cultural factors that contribute to women's health and nutritional problems before, during, and after pregnancy, and are directly linked with women's low utilization of available health services.
Many developing countries, including Botswana, Costa Rica, Cuba, Malaysia, Sri Lanka, and Thailand, have shown that it is possible to reduce the number of women and newborns who die in childbirth.
To achieve target goals in reducing maternal and newborn mortality, countries must demonstrate strong political will, sustainable investment, and a robust monitoring system. Countries cannot rely solely on external financial support. Maternal and newborn mortality reduction must be included in the national development plan and be the focus of increased budgetary allocations. Investment in maternal health is an investment in development and helps to alleviate poverty.
The continuing high incidence of maternal and newborn mortality is unacceptable, precisely because it is solvable.
Cesarean delivery reduces mortality risk in preterm breech births
December 2nd 2024In a recent study, infants born very preterm or extremely preterm had reduced odds of mortality when cesarean delivery was chosen as the mode of delivery, without a notable increase in any morbidity risk.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
Major congenital malformations not linked to first trimester tetracycline use
November 20th 2024A large population-based study found that first-trimester tetracycline exposure does not elevate the risk of major congenital malformations, though specific risks for nervous system and eye anomalies warrant further research.
Read More
No link found between prenatal cannabis use and childhood developmental delay
November 5th 2024In a recent study, offspring of women with cannabis use in early pregnancy confirmed by self-report or toxicology test were not at an increased risk of childhood early developmental delay up to the age of 5.5 years.
Read More
Prenatal cannabis use not linked to offspring ASD development
November 1st 2024In a recent study, adjustments for maternal characteristics mediated the association between maternal prenatal cannabis use and offspring autism spectrum disorder, indicating no statistically significant increase in risk.
Read More